Together, these studies support that NOS deficiency exaggerates placental ischemia-induced hypertension, but far less is understood about whether this pathway is targeted to increase the risk for PE in the face of emerging cardiovascular disease risk factors. The gene discussed is NOS1; the disease is hypertensive disorder.